Sub-Total: $0.00
Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation
March 12, 2025 @ 8:00 AM - March 12, 2026 @ 5:00 PM
CME | 1.25 Credits
Program Description
This webcast provides an update on the ocular surface diseases. Cornea and conjunctiva, lids, exocrine glands and their innervation form an integrated entity, which regulates the production of tear fluid.1 Stable tear fluid is essential in nourishing and protecting the ocular surface from external threats, such as pollution, desiccation, injuries, allergens and pathogens. Maintaining and protecting the transparent, avascular cornea is particularly important for good visual acuity. Thus, an integral part of the functioning of the ocular surface relies on the tear fluid.
Intended Audience
Ophthalmologists, optometrists, and advanced practice providers (physician assistants and nurse practitioners) who manage patients with ocular surfaces diseases.
Commercial Supporter
This activity is supported by an educational grant from Dompé US Inc.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Summarize the pathophysiology, risk factor, and evaluation of ocular surface disease
- Interpret data on artificial tear formulations and neuromodulation in managing ocular surface disease
In support of improving patient care, Amedco and MedNet have planned and implemented this activity. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. MedNet serves as the content and logistic provider for this activity. Amedco designates this activity for 1.25 AMA PRA Category 1 CreditsTM